Cargando…
Background Risk Factors Associated with Shunt Intervention for Possible Idiopathic Normal Pressure Hydrocephalus: A Nationwide Hospital-Based Survey in Japan
BACKGROUND: Patients with idiopathic normal-pressure hydrocephalus (iNPH) are typically older adults with multiple comorbidities that are associated with a reduction in the efficacy of iNPH treatment via cerebrospinal fluid (CSF) shunt placement. OBJECTIVE: The present study aimed to investigate the...
Autores principales: | Nakajima, Madoka, Kuriyama, Nagato, Miyajima, Masakazu, Ogino, Ikuko, Akiba, Chihiro, Kawamura, Kaito, Kurosawa, Michiko, Watanabe, Yoshiyuki, Fukushima, Wakaba, Mori, Etsuro, Kato, Takeo, Sugano, Hidenori, Tange, Yuichi, Karagiozov, Kostadin, Arai, Hajime |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484254/ https://www.ncbi.nlm.nih.gov/pubmed/30883349 http://dx.doi.org/10.3233/JAD-180955 |
Ejemplares similares
-
Shunt Intervention for Possible Idiopathic Normal Pressure Hydrocephalus Improves Patient Outcomes: A Nationwide Hospital-Based Survey in Japan
por: Nakajima, Madoka, et al.
Publicado: (2018) -
Lumboperitoneal Shunts for the Treatment of Idiopathic Normal Pressure Hydrocephalus: A Comparison of Small-Lumen Abdominal Catheters to Gravitational Add-On Valves in a Single Center
por: Nakajima, Madoka, et al.
Publicado: (2018) -
Preoperative Phosphorylated Tau Concentration in the Cerebrospinal Fluid Can Predict Cognitive Function Three Years after Shunt Surgery in Patients with Idiopathic Normal Pressure Hydrocephalus
por: Nakajima, Madoka, et al.
Publicado: (2018) -
Neuropsychological tests are useful for predicting comorbidities of idiopathic normal pressure hydrocephalus
por: Kamohara, Chihiro, et al.
Publicado: (2020) -
Differentiating comorbidities and predicting prognosis in idiopathic normal pressure hydrocephalus using cerebrospinal fluid biomarkers
por: Nakajima, Madoka, et al.
Publicado: (2021)